rhErythropoietin in Cancer Supportive Treatment

Fülszöveg

This important reference provides the most up-to-date assessment available on the significance of anémia in malignant disease and the application of modern molecular biology in cancer therapy. Written by over 50 internationally recognized experts, rhErythropoietin in Cancer Supportive Treatment presents the latest advances in the use of recombinant erythropoietin for the prevention of anémia in patients undergoing cancer therapy...demonstrates the efficacy of erythropoietin for maintaining hemoglobin levels...compares erythropoietin with blood transfusions in treating anémia .. .addresses the problems faced by blood transfusion services due to the increase in HTV awareness.. .highlights the impact of anémia on radiosensitivity.. .and more. With over 600 literature citations and illustrations, rhErythropoietin in Cancer Supportive Treatment is an indispensable resource for oncologists, hematologists, nephrologists, surgeons, radiotherapists, physiologists, biochemists, molecular... Tovább

Fülszöveg

This important reference provides the most up-to-date assessment available on the significance of anémia in malignant disease and the application of modern molecular biology in cancer therapy. Written by over 50 internationally recognized experts, rhErythropoietin in Cancer Supportive Treatment presents the latest advances in the use of recombinant erythropoietin for the prevention of anémia in patients undergoing cancer therapy...demonstrates the efficacy of erythropoietin for maintaining hemoglobin levels...compares erythropoietin with blood transfusions in treating anémia .. .addresses the problems faced by blood transfusion services due to the increase in HTV awareness.. .highlights the impact of anémia on radiosensitivity.. .and more. With over 600 literature citations and illustrations, rhErythropoietin in Cancer Supportive Treatment is an indispensable resource for oncologists, hematologists, nephrologists, surgeons, radiotherapists, physiologists, biochemists, molecular biologists, gynecologists, transfusion specialists, nurses, and graduate and medical school students in these disciplines. about the editors . .. john f. Smyth is Professor of Medical Oncology at the University of Edinburgh and Director of the Imperial Cancer Research Fund at Western General Hospitál, Edinburgh, Scotland. The author of over 200 professional papers, he is a Fellow of the Royal College of Physicians and the Royal College of Surgeons. Dr. Smyth received the M.D. degree (1976) from the University of Cambridge, England. Marc A. Boogaerts is Chief of the Department of Hematology and Head of the Research Department of Internál Medicine and Pathophysiology at the University Hospitál, Leuven, Belgium. The author of over 200 peer-reviewed publications, a reviewer for the British Journal of Hematology, Cancer Genetics and Cytogenetics, and the European Journal of Cancer, among other journals, he received the M.D. degree (1975) and the Ph.D. degree (1984) from the University of Leuven, Belgium. bernhard R.-M. Ehmer is Head of Medical Operations at Boehringer GmbH, Mannheim, Germany. A member of the European Society for Artificial Organs, he is the author of over 60 professional publications. Dr. Ehmer received the M.D. degree (1982) from the University of Heidelberg, Germany. Vissza